Chemed (CHE) Total Non-Current Liabilities (2009 - 2026)
Chemed (CHE) posted quarterly Total Non-Current Liabilities of $735.4 million for Q2 2026, up 45.29% year-over-year from $506.1 million in Q2 2025, and up 9.06% on a QoQ basis from $674.3 million in Q1 2026.
Chemed (CHE) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Chemed has reported Total Non-Current Liabilities for 18 years, with the latest figure at $735.4 million in Q2 2026.
- Total Non-Current Liabilities for Q2 2026 came in at $735.4 million, up 45.29% year-over-year; the trailing twelve-month figure through Jun 2026 was $735.4 million (up 45.29% YoY), and the FY2025 annual result was $545.4 million, up 1.72% from the prior year.
- Total Non-Current Liabilities improved to $735.4 million in Q2 2026, from $674.3 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $735.4 million in Q2 2026 and troughed at $506.1 million in Q2 2025.
- A 5-year average of $571.4 million and a median of $539.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The widest annual swing landed in 2023, when Total Non-Current Liabilities decreased 14.97%; it then soared 45.29% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $631.2 million in 2022, then fell by 13.3% to $547.2 million in 2023, then decreased by 2.01% to $536.2 million in 2024, then climbed by 1.72% to $545.4 million in 2025, then jumped by 34.82% to $735.4 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $735.4 million in Q2 2026, $674.3 million in Q1 2026, and $545.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.17 Bn | 88.16 Bn | 15.19 Bn | 60.86 Bn |
| 2 | Tenet Healthcare | 22.30 Bn | 20.13 Bn | 4.45 Bn | 20.20 Bn |
| 3 | Encompass Health | 12.22 Bn | 12.08 Bn | 1.34 Bn | 3.78 Bn |
| 4 | Davita | 11.68 Bn | 10.99 Bn | 1.16 Bn | 16.53 Bn |
| 5 | Ensign | 10.53 Bn | 10.21 Bn | 306.24 Mn | 3.11 Bn |
| 6 | Universal Health Services | 10.14 Bn | 10.00 Bn | 3.29 Bn | 15.38 Bn |
| 7 | Pacs | 7.07 Bn | 6.91 Bn | 338.46 Mn | 4.30 Bn |
| 8 | Chemed | 7.04 Bn | 7.00 Bn | 221.47 Mn | 735.40 Mn |
| 9 | Fresenius Medical Care AG | 6.38 Bn | 4.69 Bn | 1.52 Bn | 12.30 Bn |
| 10 | Concentra Group Holdings Parent | 4.43 Bn | 4.28 Bn | 192.10 Mn | 2.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 735.40 Mn |
| Mar 31, 2026 | 674.30 Mn |
| Dec 31, 2025 | 545.45 Mn |
| Sep 30, 2025 | 533.57 Mn |
| Jun 30, 2025 | 506.15 Mn |
| Mar 31, 2025 | 531.70 Mn |
| Dec 31, 2024 | 536.21 Mn |
| Sep 30, 2024 | 520.51 Mn |
| Jun 30, 2024 | 514.67 Mn |
| Mar 31, 2024 | 531.28 Mn |
| Dec 31, 2023 | 547.22 Mn |
| Sep 30, 2023 | 529.76 Mn |
| Jun 30, 2023 | 540.22 Mn |
| Mar 31, 2023 | 538.63 Mn |
| Dec 31, 2022 | 631.16 Mn |
| Sep 30, 2022 | 623.06 Mn |
| Jun 30, 2022 | 616.94 Mn |
| Mar 31, 2022 | 628.72 Mn |
| Dec 31, 2021 | 709.81 Mn |
| Sep 30, 2021 | 510.79 Mn |